<p>美國監管機構正在重新評估嬰兒 RSV 抗體治療，原因是疫苗懷疑者提出的擔憂，這導致羅伯特·F·肯尼迪的健康團隊啓動了安全調查。疾病控制與預防中心（CDC）的免疫實踐諮詢委員會以 8 票對 3 票的結果投票決定撤回對出生時接種乙型肝炎疫苗的普遍推薦，建議根據個體情況進行決策。如果未接種出生劑量，初始劑量應在嬰兒滿兩個月後再接種。這一審查反映了當前政府對免疫政策的持續重新審視。ACIP 的決定和相關更新可以在 Benzinga.com 上找到。</p>

賽諾菲

賽諾菲集團

阿斯利康

阿斯利康制藥

<p>美國監管機構正在重新評估呼吸道合胞病毒（RSV）治療方案，因為以 RFK Jr.為首的疫苗懷疑者提出了擔憂。美國疾病控制與預防中心（CDC）的免疫接種諮詢委員會（ACIP）以 8 票對 3 票的結果投票決定取消對出生於陰性母親的嬰兒的普遍乙型肝炎疫苗接種建議，建議採取個體化決策。賽諾菲和阿斯利康正在為 RSV 季節做準備，因為 beyforetus 的產量增加了三倍</p>

<p>U.S. regulators are re-evaluating infant RSV antibody treatments following concerns raised by vaccine skeptics, which led Robert F. Kennedy Jr.'s health team to initiate safety inquiries. The CDC's Advisory Committee on Immunization Practices voted 8-3 to retract the universal recommendation for hepatitis B birth-dose vaccine for infants born to hepatitis B surface antigen-negative mothers and suggested individual-based decision-making. If the birth dose is not administered, the initial dose should be given no earlier than two months of age. This review reflects the ongoing re-examination of immunization policies by the current administration. ACIP's decision and related updates can be found on Benzinga.com.</p>
<div class="lb-trans"><p>美國監管機構正在重新評估嬰兒 RSV 抗體治療，原因是疫苗懷疑者提出的擔憂，這導致羅伯特·F·肯尼迪的健康團隊啓動了安全調查。疾病控制與預防中心（CDC）的免疫實踐諮詢委員會以 8 票對 3 票的結果投票決定撤回對出生時接種乙型肝炎疫苗的普遍推薦，建議根據個體情況進行決策。如果未接種出生劑量，初始劑量應在嬰兒滿兩個月後再接種。這一審查反映了當前政府對免疫政策的持續重新審視。ACIP 的決定和相關更新可以在 Benzinga.com 上找到。</p>
</div>

US regulators re-evaluating RSV treatment amid concerns from vaccine skeptics led by RFK Jr. CDC recommends individual-based decision-making on hepatitis B vaccine for infants born to negative mothers. ACIP votes 8 to 3 to lift universal recommendation. beyforetus output triples as Sanofi, AstraZeneca gear up for RSV season.